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THE priiLiary objects ofthis investigation were: (a) to confirm the observation
miade by previous workers, notably Noble, McEuen and Collip (1940), Geschickter
and Byrnes (1942), Nelson (1944) and Dunning, Curtis and Segaloff (1947), that
mammary cancer can be induced in rats by prolonged stimulation with oestrogenic
substances; and (b) to determine whether there is any variation in the response
of different strains of rats to the carcinogenic action of these oestrogens on their
mammary glands.
In general, it may be said that the results obtained amply confirm the previous
reports with regard to the production of malignant tumours in rats by oestrogens,
but that these results appear to vary with the strain of rat employed.
Certain other facts were noted in the course ofthe experiment and these will be
discussed in due course.
MATERIALS AND -METHODS.
Rats of three different strains were used in these experiments:
(a) Albino rats obtained from the research laboratories of the Royal Cancer
Hospital, London. These were the descendants of animals which had originally
been obtained from a commercial source, and had been bred in a random fashion
for a good number of years; brother-to-sister miating had never been attempted.
An exceedingly low proportion, one in many thousands, develop simple adenoma
of the breast, sometimnes multiple, but a malignant tumour of the breast has never
been seen. For the purposes of this investigation, six male and six female rats,
all young aduilts, were obtained and the animials used in these experiments were
bred froin them by random mating.
I am indebted to Professor A. Haddow ofthe Chester Beatty Research Institute
for the supply of these animals and for the details of their previous history.
(b) Albino rats obtained from the Glaxo laboratories, known as WAG rats.
They were originally derived from the Wistar albino strain and had been main-
tained by brother-to-sister mating from the time of their introduction to the
Glaxo laboratories; when the animals used in these experiments were first
obtained about 50 generations had been so bred.
Spontaneous mammary cancer is extremely rare in this strain, though exact
figures are unfortunately not available. For the purposes of this investigation,
12 male and 12 female young rats (5 weeks old) were originally obtained. Twelve
of these (6 male and 6 female) were kept for breeding purposes, brother-to-sister
mating being continued, and from these 6 pairs were bred the animals designatedMAMMARY CANCER IN RATS
WAG rats intheseexperiments. Theremaining 6pairs were usedforexperimental
purposes.
(c) Black and white (hooded or piebald) rats maintained in the laboratories of
the Medical School, Newcastle upon Tyne, formed the third group. They are
descendants of rats which had been obtained from a colony at the M.R.C.
laboratories at Mill Hill. This colony was derived from black and white rats
which had been obtained from the laboratories of Imperial Chemical Industries
someyearspreviously, andtheyintheirturnweredescendedfrom animalsobtained
from the Lister Institute which were reputed to be derived originally from hooded
rats of the Wistar Institute. In the M.R.C. laboratories they had been kept for
several years as a closed colony, but breeding was by random mating, no true
inbreeding having been attempted. In Newcastle this method of breeding was
continued and young animals were obtained from these matings as required for
the experiments. No accurate figures as to the occurrence of spontaneous mam-
mary tumours in this strain are available, but in the I.C.I. laboratories it had been
found that a good many ofthe older females developed benign mammary tumours
(fibro-adenomata), and occasionally a mammary carcinoma was noted. For the
duration ofthe experiments recorded here, a period ofabout two and a halfyears,
all the adult animals in the colony were examined periodically for mammary
tumours; out of several hundred animals, five such tumours, which will be de-
scribed later, were found.
It will thus be evident that, of the three strains, only one (Glaxo WAG rats)
can be described as a pure strain, comparable to similar strains of mice. Of the
other two, the Cancer Hospital stock may be regarded as semi-inbred, while the
hooded rats were probably the least inbred of the three groups.
The rats were fed throughout the experiments on a diet of rat cake of the
following composition (as obtained from the makers, The North-Eastern Agri-
cultural Co-operative Society, Abderdeen):
Dried Milk 7 . . . 7.*)
Oil . . . . . . . 4- 4
Albumnoids 2. . . . 203
Fibre . . . . . . 4 3
Carbohydrates . . . . . 51 6
Salt . . . . . . 0- 9
CaCO3 . . . . . 3.3
Moisture to . . . . . 100
This diet was supplemented by green vegetables and an unlimited supply of
clean drinking-water was always available.
The oestrogens used were (a) oestradiol (Organon), (b) oestradiol dipropionate
(Ciba) and (c) stilboestrol (Organon). These were implanted as pellets weighing
5-6 mg., which were made from the crystalline substances by a specially designed
hand compression machine. Every rat was implanted with two such pellets of
the same substance, the initial implant being made at the age of 4 weeks, into
the muscles of the lumbar region on one side through a small skin incision, which
was then sutured; the secondimplant was made 1-3 months later into the lum-
bar muscles of the opposite side in a similar fashion.
The animals were examined for mammary tumours at regular intervals, and at
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death a complete post-mortem examination was carried out, a search being made
for gross tumours of all organs. Portions of the mammary glands (where these
had not atrophied completely, as happened in a considerable number of animals),
thyroid, adrenals, sex organs, pituitary and any other tissues of interest were
preserved for microscopic section. A search was also made at the sites ofimplant-
ation of the pellets, but in the great majority of the animals these had been
absorbed completely by the time death occurred; in the few cases where they were
still present they were less than half their original weight. In no instance was
there any evidence of local tumour production.
RESULTS.
The total number ofexperimental animals (female) used was 140. TableI sum-
marises the numbers of each type of rat used,the numbers implanted respectively
with oestradiol, or its dipropionate derivative, and stilboestrol, and the number
of malignant mammary tumours obtained. These results are shown graphically
in Fig. 1-6.
TABLE I.-Mammary Cancers Developing in Rats Treated with Oestrogens.
Numbers
Strain employed
of (females
rat. only).
WAG . . 46
Cancer Hospital . 61
Newcastle hooded . 33
Total . . 140
Number implanted
with:
Oestradiol
or
oestradiol
dipro- Stil-
prionate. boestrol.
29 17
38 23
25 8
92 48
Number with
Mammary cancer.
Stil-
Oestradiol boestrol
group. group.
10 0
2 1
6 2
18 3
Total.
r
Per
Number. cent.
10 22
3 5
8 24
21 15
General Observations.
The animals implanted with oestradiol or its dipropionate showed a definite
retardation of growth as compared with unimplanted controls. This retardation
in growth rate began as soon as they had been implanted and was progressive,
the average weight at death being about 110 g. as compared with an average
weight of225 g. for the unimplanted controls. On the otherhand, this retardation
in growth and difference in weight was not nearly so marked among those animals
implanted with stilboestrol, in which group the average weight at death was
210 g. (these figures refer to females only) (Table II).
TABLE II.-Retardation of Gro
Rats N
implanted
with:
Oestradiol or oestradiol dipropionate
Stilboestrol
Controls
)wth of Female Rats Implanted with
lumbers with Average
pituitary body-weight
tumours. at death.
69
(out of 92)
19
(out of 48)
0
g-
110
210
225
Average
pituitary
weight.
mg.
320
34 . 13-5-90
14- 5 9-24
Oestrogens.
Range of
pituitary
weight.
mg.
29-606
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In addition to this retardation in weight the oestradiol implanted animals
showed loss of activity and partial loss of hair. They also frequently showed
ataxic symptoms, which were associated with the increased size ofthe pituitary.
The stilboestrol implanted animals on the other hand showed little or no loss of
activity, no loss of hair and only occasionally mild ataxic symptoms.
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Histology.
It was foundthatthe changes produced by (a) the naturally occurring oestrogen
oestradiol, and its dipropionate derivative, and (b) the synthetic oestrogen di-ethyl-
stilboestrol, were sufficiently distinct as to allow of their being discussed separ-
ately.
(a) Oestradiol and oestradiol dipropionate.
No qualitative difference in the effects produced by these two substances on
the mammary tissue of rats was noted. The numbers of animals of the different
strains used were not large enough to allow of any conclusions being drawn as to
any quantitative difference in their effects.
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In a considerable number of the experimental animals the main effect on the
breast tissue was one ofatrophy, the mammary tissue being scarcely visible to the
naked eye and, microscopically, consisting of a few acini and ducts in a very
scanty stroma. The typical reaction, however, was one of cyst formation, the
microscopic appearance being somewhat analogous to that of human chronic
cystic mastopathy. There was, however, one major difference between the
experimental condition in the rat and the naturally occurring human condition,
and that lay in the degree ofstromal reaction present. In the rat this was minimal,
though there was some variation between different animals. The typical picture
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was of numerous cysts of varying size, a few being sufficiently large to be visible
to the naked eye, lined by cubical or flattened epithelium and filled with an
eosinophilic structureless material in which desquamated cells or cell nuclei were
sometimes visible. In some cases epithelial proliferation of the cells lining the
cyst walls was seen and in a few this took the form of papillary ingrowths. In
the majority of cases this proliferation was benign, but occasionally the cellular
appearance suggested a pre-malignant change (Fig. 7).
Malignant change. In 18 animals with malignant mammary tumours 10 had
only one mamma involved, while in the remainder there were multiple tumours.
The histological picture varied from animal to animal, from one tumour to
another in the same animal and in different parts of the same tumour but, in
general, several different types could be distinguished. These were (a) adeno-
carcinoma, which was not common; (b) papillary carcinoma (Fig. 8); and (c)
I
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anaplastic carcinoma (carcinoma simplex), in which the cells were spheroidal in
type and arranged in masses. A feature of many of the tumours was the occur-
rence of squamous metaplasia, which in some cases was very well marked, while
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in others it was seen only in one small area of the section (Fig. 9). It was never
seen in any ofthe control mammae examined, nor in those ofexperimental animals
which showed only atrophy or cystic mastopathy without malignant change.
The amount of fibrous tissue stroma in the tumours varied. In some it was
minimal, but in the majority there was quite a well-defined stroma; in only two
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instances, however, was there anything analogous to the typical scirrhous carci-
noma of the human breast, and then only in a portion of the tumour.
Involvement ofthe entire breast in the malignant process was not uncommon,
while in other instances the tumour was confined to a portion of the mamma, the
remainder showing the cystic appearance already described. Invasion of the
muscular layer underlying the breast, by malignant cells, occurred in some cases,
but in no instance were distant metastases noted.
(b) Diethyl-stilboestrol.
The effects of this substance on the mammary glands differed noticeably from
that ofthe naturally occurring oestrogen and its derivative. (1) There was much
less tendency to atrophy of the glands which, in the majority ofthe experimental
animals, were well formed. (2) Cystic dilatation ofthe ducts and acini was fairly
frequent but, in addition, there was frequently a marked but perfectly regular
proliferation ofthe acini-adenosis. In some this resulted in well-defined systems
of lobules, resembling the appearance of pre-lactational breasts in the controls,
while in others the arrangement was more haphazard, though still quite benign.
(3) There was usually a greater amount of fibrous tissue stroma in these glands,
though it varied considerably, and in some there was very little. (4) Simple
tumours, which occurred only once inthe firstgroup, werefound inseveral animals.
These were: (a) true adenomata each consisting of a mass of regularly formed
acini, whose lining cells were perfectly regular, the whole being well encapsuled in
the breast substance; and (b) fibroadenomata in which the histological picture
was that of an abundant fibrous tissue proliferation in which acini were embedded
and compressed, and resembling very markedly the corresponding benign human
tumour. (5) Only three malignant tumours occurred. Two of these were
adenocarcinomas (Fig. 10), the third being a carcinoma simplex. Nothing
resembling the varied histological structure of the first group was seen in them
and squamous metaplasia did not occur.
Mammary tumours in control rats.
No mammary tumours were found in the animals of the control groups of
WAG and Cancer Hospital rats. These groups were not large, but were approxi-
mately equal in numbers to, and of considerably longer average lifespan than, the
animals in the experimental groups.
As the data on the occurrence ofspontaneous tumours in the Black and White
(hooded) strain were scanty several hundreds of these animals in the colony were
kept under observation as controls during the period of the experiment. Among
these five breast tumours were noted, as follows:
(1) A male, 409 days old, had two tumours, one in each flank in the lumbar
region, 3 cm. and 2*5 cm. in diameter respectively. The histological appearance of
each was identical, bothbeinginvasive, pleomorphic spindle-cell sarcomatawithno
evidence of epithelial elements (Fig. 11). Their positions suggested a mammary
origin, but the histological appearance did not tend to support this.
(2) Two female rats, both 458 days old (born on the same day and probably,
though not certainly, litter mates), each had a tumour in the left inguinal mamma,
the one measuring 3-5 cm. and the other 5 cmp, in diameter, ]3otki were fibro-
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adenomata in which the epithelial elements were predominant, but whereas in the
one the stroma was scanty and surrounded the lobules into which the tumour
was divided, in the other it was more abundant, oedematous in appearance and
penetrated into and subdivided the lobules.
(3) A female rat, 606 days old, had a tumour in the right axillary breast
measuring 1-5 cm. in diameter. Histologically, it was a fibroadenoma with a
marked preponderance of fibrous tissue stroma, the epithelial elements being
scanty and compressed (Fig. 12).
Effects on the pituitary gland.
A constant feature ofthe findings in the experimental animals was enlargement
of the pituitary, though the degree of enlargement varied widely in different
animals. Table II shows the average weight ofthe pituitary in the groups treated
with oestradiol (or its dipropionate derivative) and stilboestrol, compared with
the average weight of the gland in normal controls. The average body weights
at death in the different groups are also shown.
In estimating the weight of the pituitary the gland was first removed entire
and fixed in 10 per cent formol-saline. It was then removed from the fixative,
all excess moisture removed with absorbent paper, and thereafter it was weighed
on a sensitive chemical balance.
It was noticeable that the larger glands were found in animals which showed
the greatest degree of weight loss and ataxia and that generally speaking the
enlargement was considerably greater in the oestradiol treated groups than in the
stilboestrol treated group.
In all instances the gland was removed from its surroundings without difficulty
and nothing was seen to suggest, to the naked eye, that invasion of the adjacent
structures had occurred.
Microscopy.-The microscopic findings were uniform, with some minor and
one major difference. The proliferating cells were the chromophobes, and while,
in some of the small glands, numbers of eosinophil cells and fewer basophil cells
were seen, in the larger glands these were absent. These chromophobe cells were
arranged in columns or masses in close association with thin-walled blood channels
and were of uniform size and shape. The nuclei were as a rule well formed,
though pyknosis was fairly frequent. No undue nuclear activity was noted and
nothing was seen to suggest the occurrence of malignant change. The blood
channels were numerous and thin-walled and varied in size, the largest channels
being found in the larger glands. Not infrequently areas of haemorrhage (some
quite large) had occurred into the substance of the glands.
One quite marked difference was noted between the oestradiol-treated and the
stilboestrol-treated groups. Whereas in the former, an occasional gland showed
a cyst-like space containing a structureless eosinophilic colloid material; this was
of frequent occurrence in the stilboestrol-treated group. Commonly, there were
several such colloid-filled spaces scattered through the substance of the gland in
the latter group of animals, though, as noted above, they were on the average
considerably smaller than in the oestradiol group. This may indicate that the
pituitary cells were still functioning with some degree of normality in the stil-
boestrol group, whereas their secretory function was grossly impaired (if not
cntirely lost) in the oestradiol treated animals,
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Other tumours in experimental animals.
Benign tumours.-A fairly frequent finding was an enlargement of one or both
ovaries, which in some cases was very marked, the tumours measuring up to
295-4 cm. in diameter. This enlargement was due to simple cyst formation, a
thin wall containing fluid contents or semi-solid or inspissated caseous material.
Microscopically the wall was composed of connective tissue of varying thickness
with an epithelial lining; in the larger cysts the latter was not always present.
It was noticeable that whereas in the animals implanted with oestradiol or its
dipropionate the content was almost always composed of an inspissated caseous
material; in those implanted with stilboestrol it was generally fluid.
Occasionally similar tumours were found in the control groups, but they never
reached the size seen in many of the experimental animals.
Malignant tumours.-Four extra-mammary malignant growths were observed
in the experimental animals. Two of these were ovarian (Fig. 13), and 2 were
uterine in origin (Fig. 14). They all occurred in animals implanted with stil-
boestrol, 3 of them in Cancer Hospital rats and the fourth (which was uterine) in
a hooded rat. Their ages at death varied from 381 days to 602 days.
Microscopically all the tumours were squamous epitheliomata showing wide-
spread local invasion, but no definite metastases were found.
No such malignant tumours were found in any of the control animals.
DISCUSSION.
Production of mammary tumours in rats.
The results of these experiments in general corroborate the observations of
others on the occurrence of mammary cancer in rats following the prolonged
stimulation of these animals by oestrogenic substances, and help to clarify the
discrepancies inthe incidence ofsuch tumours in the various recorded experiments.
In spite of much experimental work on the effects of oestrogens on rats (Hartwell
(1951) has listed some 130 papers on the subject between 1930 and 1947), both
male and female, intact and castrated, only a relatively small number ofworkers
have obtained mammary tumours in these animals.
A study of the methods employed in these experiments however quickly
reveals the reasons for this divergence in results, and helps to indicate the experi-
mental conditions requiring to be employed in order to obtain such tumours.
These conditions can be summarized under two main headings: (a) the
experimental animals and (b) the oestrogenic stimulation. With regard to the
former the following points are of importance.
(a) Numbers.-In a species such as the rat, in which naturally-occurring
mammary tumours are very uncommon, one may reasonably assume that the
incidence of experimental tumours, using any given strain, may not be high and,
accordingly, a sufficient number of animals must be included in the experimental
series to allow forthis. Too many oftheexperiments hitherto recordedhave made
use of far too small numbers of animals, and it is noteworthy that, in those
experiments in which tumours have been recorded, the numbers of animals used
have been much more adequate.
(b) Sex.-For the same reason female rats should be used first in any explor-
ation of the experimental production of mammary cancer. Once the fact has
been established that such tumours can be obtained in any given strain, then the
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investigation of their production in males and in castrated or otherwise abnormal
animals can be undertaken.
(c) Age. The demonstration of the milk-agent in mammary cancer of mnice
and the fact that it may lose its effectiveness as the age of the animal increases
before being infected (Andervont, 1945), shows that the process which determines
the development of these tumours in mice is effective from a very early age.
One may assume as a working hypothesis that a similar process, if present in
another species, may work in much the same manner, and therefore the younger
the animals are when the experimental conditions are begun the better.
It is noteworthy that the workers who have successfully produced mammary
tumours in rats have all used young animals, the ages varying from 5-7 days
(Noble, McEuen and Collip, 1940) to 3-4 months (Dunning, Curtis and Segaloff,
1947) though Geschickter and Byrnes (1942) were also able to produce tumours in
animals up to 9 months old at the beginning ofthe experiment. In such animals,
however, large doses of a particularly potent oestrogen were required. An
exception to this generalization is the work of Eisen (1942) who was able to obtain
only two mammary tumours among 134 rats which were 3-5 weeks old at the
beginning of the experiments ; a possible reason for this low incidence is discussed
below.
In the experiments recorded inthis paper the age ofthe animals atthe beginning
of the experiments was standardized at 28 days, thus eliminating any discrepancy
due to difference in age.
Strain.-In mice the existence ofstrains with an incidence ofmammary cancer
varying from zero to a high percentage has long been known and the demon-
stration of the presence or absence of the milk agent in such strains indicates the
reason for the varying incidence. In no other species have such nearly homo-
zygous strains been developed, but in quite a number of laboratories both in this
country and the United States groups ofrats have been inbred over a considerable
number of years, to such an extent that though the breeding methods uised have
not been of the standard used in mice, yet it may be reasonably assumed that the
animals within each group are closely related genetically and that one group
differs from another at least as much as do the different races of mankind. Such
an assumption may help to explain the varying incidence of mammary tumours
obtained by different workers and emphasizes the necessity for an investigation
of the incidence of such tumours in different strains of rats under strictly com-
parable experimental conditions.
EXPLANATION OF PLATES.
Fia. 7.-Section of breast frorm oestradiol treated rat showing precancerous proliferation Nwithin
the ducts. X 128.
FIG. 8.-Section of breast from oestradiol treated rat showing papillary carcinoma. x 128.
FIG. 9.- Breast from oestradiol treated rat showing spheroidal cell carcinoma with squtamous
metaplasia. x 128.
FIG. 10. Breast from stilboestrol treated rat showing adenocarcinoma. x 128.
FIG. 11.-Section of breast tumour from control rate (hooded). Pleomorphic celled sarcoma.
x 128.
FIG. 12.-Section of fibro-adenomatous tumour from breast of control rat. x 128.
FIG. 13.-Section showing carcinoma of the ovary from a stilboestrol treated rate. x 128.
FIG. 14.-Section showing carcinoma of uteruis in a stilboestrol treated rat. x 128.
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The results obtained in the experimental part ofthis paper indicate that there
is indeed a considerable difference in susceptibility among different strains ofrats,
and from these results and those of others one can divide them provisionally into
high, medium and low cancer strains. Table III shows the strains, so far tested,
assigned to each group.
TABLE III.-Showing Susceptibility to the Development of Mammary Cancer by
Oestrogen Stimulation among Strains of Rats so far Tested.
High cancer strains. Medium cancer trains. Low cancer strains.
Per Per Per
cent. cent. cent.
Tlooded rats (Unknown 55 . Inbred albino rats 36-4 . Inbred Sherman rats 1-5
ancestry) (Noble et al., (Geschickter and (Eisen, 1942)
1940) Byrnes, 1942)
Long-Evans hooded rats 66 . A x C line 9935 (Dun- 33 . Copenhagen line 2331 0
(Nelson, 1944) ning et al., 1947) (Dunning etal., 1947)
Newcastle hooded rats 24 . Fischer line 344 (Dun- 6-3
(MacKenzie) ning et al., 1947)
WAG rats (Mac- 21-7 Cancer Hospital rats 5
Kenzie) (MacKenzie)
It should be stressed however that these figures are not strictly comparable,
in that (a) the ages of the animals at the beginning of the various experiments
varied and (b) the oestrogen used, its dosage and method of administration also
varied. Further work requires to be done to clarify and extend this observation.
Oestrogenic substances employed.
A considerable number of oestrogens have been used by various workers and
Table IV summarises the results obtained. It should be emphasized, however
that the experimental conditions under which they were used differed widely,
and the fact that no tumours were obtained with any particular substance does
not necessarily imply that it does not possess tumour-evoking properties. Until
they have all been tested under identical conditions of dosage and time, using a
strain of rats of known susceptibility, no definite conclusions can be drawn. In
the present work tumours were obtained with both oestradiol and its dipropionate
derivative, but the experimental conditions used were not such as to warrant any
conclusions being drawn as to their relative effectiveness. Stilboestrol, on the
other hand, while evoking the usual cystadenosis and occasional benign tumour,
produced only 3 malignant tumours among 48 animals in these experiments.
In view of the positive results obtained by others (Geschickter and Byrnes, 1942;
Nelson, 1944; Dunning, Curtis and Segaloff, 1947) there must be some reason for
this, and a review ofthe methods used by these workers suggests that this may be
a matter of dosage. The amount used in the present experiments was a total of
10 mg. implanted intramuscularly as 2 pellets, whereas both Nelson and Dunning
and his co-workers used a larger quantity. The latter workers, recognising
that stilboestrol alone is absorbed fairly rapidly, incorporated it in pellets mixed
with cholesterol in the proportion of 1 to 4. This greatly slowed the rate of
absorption of the stilboestrol, and only after they had done so were they able to
obtain breast tumours in their experimental animals. Geschickter and Byrnes
(1942), on the other hand, were regularly able to obtain breast tumours with no
more than 10 mg. of stilboestrol implanted subcutaneously as pellets, However,
295I. MACKENZIE
the general appearance of the stilboestrol implanted animals in the present series
(particularly their weight and the relatively small increase in size of their
pituitaries) strongly suggested that the dosage was inadequate, and further work
utilizing in particular the technique of Dunning, Curtis and Segaloff (1947), is
required to clarify this point.
TABLE IV.-List of Oestrogens Employed Experimentally in Rats.
(Summarized from Hartwell, 1951)
Oestrogen.
Oestradiol
benzoate
dipalmitate
dipropionate
Oestradiol-17-caprylate
Oestradiol di-n-butyrate
, di-caprate
di-n-hexanoate
di-isobutyrate.
di-n-octanoate
Oestradiol-3-benzoate-17-aceta
Oestradiol-3-benzoate-I 7-butyi
Oestradiol-3-benzoate-17-propi
Oestradiol-3-benzoate-17n-vale
Oestradiol-3n-butyrate- 17-ben:
Oestriol
Oestrone
Oestrone benzoate
Oestrone-n-hexanoate
Oestrone-n-octanoate
Stilboestrol (4,4'-dihydroxy-oct
stilbene)
Stilboestrol mono-methyl ethei
,, 31 di-methyl ether
Breast tumours.
Tumours obtained (Geschickter and Bymes, 1942;
MacKenzie).
. Tumours obtained (Mark and Biskind, 1941; Ges-
chickter and Byrnes, 1942).
No tumours.
Tumours obtained (Eisen, 1942; Geschickter and
Byrnes, 1942; MacKenzie).
No tumours.
tte.
rate . . .
ionate
-rate .
zoate .
Tumours obtained (McEuen, 1938; Geschickter, 1939a,
1939b; Geschickter and Bymnes, 1942; Noble et al.,
1940; Nelson, 1944).
Tumours obtained (Chamorro, 1943).
No tumours.
No tumours.
3 diethyl- Tumours obtained (Geschickter and Byrnes, 1942;
Nelson, 1944; Dunning et al., 1947; MacKenzie).
r} . Tumours obtained (Geschickter and Byrnes, 1942).
The substances which have so far been successfully used in the production of
breast tumours are oestradiol and its benzoate and dipropionate derivatives-
oestrone and oestrone benzoate-and stilboestrol and its mono- and di-methyl
derivatives. Ofthese Geschickter and Byrnes (1942) regarded oestradiol benzoate
as the most effective.
Dosage.-Table V gives the dosages used in the various successful experiments,
and it will be seen that they vary considerably. However, from a study of the
various papers it would seem probable that a minimum of 10 mg. in pellet form of
an active oestrogen is required to produce mammary cancer in rats and this agrees
substantially with the conclusions reached by Geschickter and Byrnes (1942).
In the case of a substance such as stilboestrol, which is rapidly absorbed, some
agent like cholesterol, which retards absorption, should be mixed with it before
the pellets are made.
Method of Administration.-Two methods have been used: (a) subcutaneous
injection of the pure substance dissolved in oil and (b) subcutaneous or intra-
muscular implanation of pellets of the pure substance or of the pure substance
mnixed with cholenterol. Both ofthese miethods have been successful in producing
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tumours. The difference between them lies in the method ofabsorption, which in
the one case is discontinuous while in the other there is a continuous gradual
absorption ofthe active substance, with the result that a considerably smaller total
dose is required to produce the desired effect. Geschickter and Byrnes (1942)
found that only one third to one half of the amount given by daily injection was
required to produce mammary cancer if given in the form of pellet implants;
in addition, the great saving in labour need not be stressed. With regard to the
vehicle in which the active substance is given, when the injection technique is
used it is dissolved in some oil, such as corn oil or olive oil. Pellets are made of
the pure substance, but, as already noted, Dunning Curtis and Segaloff (1947)
have demonstrated the value of mixing it with cholesterol when stilboestrol is
being used. Eisen (1942), however, used oestradiol dipropionate dissolved in
liquified paraffin which, when cooled in the body, formed a solid wax pellet from
which the active substance was gradually absorbed. However, these pellets
appeared to evoke a marked acellular connective tissue reaction around them and
it is possible that the rate of absorbtion was much reduced, thus accounting for
the low incidence of tumours which he obtained.
Duration ofstimulation.-From Table V it will be seen that the time from the
onset ofoestrogenic stimulation to the appearance ofpalpablenodules ofmammary
cancer varies considerably. This may well be a product of three variables: (a)
strain ofrat, (b) type ofoestrogen, and (c) dosage; and it is difficult to know what
the relative importance of each factor may be. From the figures, however, it
appears that palpable nodules are unlikely to appear in less than 120 days, though
tumours may be discovered microscopically before that. Therefore any
experiment must be continued either (a) until the appearance of a tumour or (b)
until the death of the animal. In the present experiments the earliest tumour
was noted about the 230th day after the beginning of oestrogenic stimulation,
but others developed much later than this. Geschickter and Byrnes (1942)
found that the time of appearance of a tumour depended largely on the dosage of
oestrogen given, the larger the dose within a given limit (200,ug. daily in the case
of oestrone) the earlier the tumours appeared. Also they state that the older the
animal is at the onset of stimulation the larger the dose must be to cause the
the appearance of cancer. Amounts greater than the optimum did not decrease
the time of appearance of the tumours, nor increase the number of animals with
tumours.
SUMMARY.
1. Female rats of three different strains were implanted with oestradiol,
oestradiol dipropionate, or stilboestrol, and kept under observation till they died.
2. Out of a total of 140 female animals, 21 developed malignant mammary
tumours, some of them showing multiple tumours.
3. Four animals developed malignant tumours of the ovary or uterus.
4. The experimental conditions necessary to the production of malignant
tumours of the breast in rats are discussed.
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